• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光学相干断层扫描血管造影视网膜成像与脑小血管疾病负担及淀粉样蛋白阳性的关联

Optical Coherence Tomography Angiography Retinal Imaging Associations With Burden of Small Vessel Disease and Amyloid Positivity in the Brain.

作者信息

Bermudez Camilo, Lesnick Timothy G, More Swati S, Ramanan Vijay K, Knopman David S, Rabinstein Alejandro A, Cogswell Petrice M, Jack Clifford R, Vemuri Prashanthi, Petersen Ronald C, Graff-Radford Jonathan, Chen John J

机构信息

Department of Neurology (CB, VKR, DSK, AAR, RCP, JG-R, JJC), Mayo Clinic, Rochester, Minnesota; Center for Drug Design (SSM), College of Pharmacy, University of Minnesota, Minneapolis, Minnesota; Departments of Radiology (PMC, CRJ, PV) and Ophthalmology (JJC), Mayo Clinic, Rochester, Minnesota; and Department of Quantitative Health Sciences (TGL), Mayo Clinic, Rochester, Minnesota.

出版信息

J Neuroophthalmol. 2025 Mar 1;45(1):63-70. doi: 10.1097/WNO.0000000000002230. Epub 2024 Aug 1.

DOI:10.1097/WNO.0000000000002230
PMID:39085998
Abstract

BACKGROUND

Alzheimer disease (AD) and other dementias are associated with vascular changes and amyloid deposition, which may be reflected as density changes in the retinal capillaries. These changes may can be directly visualized and quantified with optical coherence tomography angiography (OCTA), making OCTA a potential noninvasive preclinical biomarker of small vessel disease and amyloid positivity. Our objective was to investigate the feasibility of retinal imaging metrics as noninvasive biomarkers of small vessel disease and amyloid positivity in the brain.

METHODS

We investigated associations between OCTA and neuroimaging and cognitive metrics in 41 participants without dementia from the Mayo Clinic Study of Aging and Alzheimer's Disease Research Center. OCTA metrics included superficial, deep, and full retina capillary density of the fovea, parafovea, and macula as well as the area of the foveal avascular zone (FAZ). Neuroimaging metrics included a high burden of white matter hyperintensity (WMH), presence of cerebral microbleeds (CMB), lacunar infarcts, and amyloid positivity as evidenced on positron emission tomography (PET), whereas cognitive metrics included mini-mental status examination (MMSE) score. We performed generalized estimating equations to account for measurements in each eye while controlling for age and sex to estimate associations between OCTA metrics and neuroimaging and cognitive scores.

RESULTS

Associations between OCTA and neuroimaging metrics were restricted to the fovea. OCTA showed decreased capillary density with high burden of WMH in both the superficial ( P = 0.003), deep ( P = 0.004), and full retina ( P = 0.01) in the fovea but not the parafovea or whole macula. Similarly, participants with amyloid PET positivity had significantly decreased capillary density in the superficial fovea ( P = 0.027) and deep fovea ( P = 0.03) but higher density in the superficial parafovea ( P = 0.038). Participants with amyloid PET positivity also had a significantly larger FAZ ( P = 0.031), whereas in those with high WMH burden the difference did not reach statistical significance ( P = 0.075). There was also a positive association between MMSE and capillary density of the full retina within the fovea ( P = 0.037) and in the superficial parafovea ( P = 0.046). No associations were found between OCTA metrics and presence of CMB or presence of lacunar infarcts.

CONCLUSIONS

The associations of lower foveal capillary density with cerebral WMH and amyloid positivity suggest that further research is warranted to evaluate for shared mechanisms of disease between small vessel disease and AD pathologies.

摘要

背景

阿尔茨海默病(AD)和其他痴呆症与血管变化和淀粉样蛋白沉积有关,这可能表现为视网膜毛细血管密度的变化。这些变化可通过光学相干断层扫描血管造影(OCTA)直接可视化和量化,使OCTA成为小血管疾病和淀粉样蛋白阳性的潜在非侵入性临床前生物标志物。我们的目的是研究视网膜成像指标作为大脑中小血管疾病和淀粉样蛋白阳性的非侵入性生物标志物的可行性。

方法

我们在梅奥诊所衰老与阿尔茨海默病研究中心的41名无痴呆症参与者中,研究了OCTA与神经影像学及认知指标之间的关联。OCTA指标包括中央凹、旁中央凹和黄斑的浅层、深层及全视网膜毛细血管密度,以及中央凹无血管区(FAZ)的面积。神经影像学指标包括高负担的白质高信号(WMH)、脑微出血(CMB)的存在、腔隙性梗死,以及正电子发射断层扫描(PET)显示的淀粉样蛋白阳性,而认知指标包括简易精神状态检查(MMSE)评分。我们进行了广义估计方程分析,以考虑每只眼睛的测量数据,同时控制年龄和性别,以估计OCTA指标与神经影像学及认知评分之间的关联。

结果

OCTA与神经影像学指标之间的关联仅限于中央凹。OCTA显示,中央凹浅层(P = 0.003)、深层(P = 0.004)和全视网膜(P = 0.01)的毛细血管密度随着WMH高负担而降低,但旁中央凹或整个黄斑区未出现这种情况。同样,淀粉样蛋白PET阳性的参与者中央凹浅层(P = 0.027)和深层(P = 0.03)的毛细血管密度显著降低,但旁中央凹浅层的密度较高(P = 0.038)。淀粉样蛋白PET阳性的参与者的FAZ也显著更大(P = 0.031),而WMH负担高的参与者之间的差异未达到统计学显著性(P = 0.075)。MMSE与中央凹内全视网膜(P = 0.037)和旁中央凹浅层(P = 0.046)的毛细血管密度之间也存在正相关。未发现OCTA指标与CMB的存在或腔隙性梗死的存在之间存在关联。

结论

中央凹较低的毛细血管密度与脑WMH和淀粉样蛋白阳性之间的关联表明,有必要进一步研究以评估小血管疾病和AD病理之间疾病的共同机制。

相似文献

1
Optical Coherence Tomography Angiography Retinal Imaging Associations With Burden of Small Vessel Disease and Amyloid Positivity in the Brain.光学相干断层扫描血管造影视网膜成像与脑小血管疾病负担及淀粉样蛋白阳性的关联
J Neuroophthalmol. 2025 Mar 1;45(1):63-70. doi: 10.1097/WNO.0000000000002230. Epub 2024 Aug 1.
2
MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.马克 VCID 脑小血管联盟:二、神经影像学协议。
Alzheimers Dement. 2021 Apr;17(4):716-725. doi: 10.1002/alz.12216. Epub 2021 Jan 21.
3
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.抗血栓治疗预防神经影像学检查发现的小血管疾病但无痴呆的患者认知能力下降。
Cochrane Database Syst Rev. 2022 Jul 14;7(7):CD012269. doi: 10.1002/14651858.CD012269.pub2.
4
Retinal Vascular Parameters Changes (by Optical Coherence Tomography Angiography) in Early Rheumatoid Arthritis: A Hospital-Based Study.早期类风湿关节炎患者视网膜血管参数变化(通过光学相干断层扫描血管造影):一项基于医院的研究
Ocul Immunol Inflamm. 2025 Jul;33(5):812-818. doi: 10.1080/09273948.2025.2460642. Epub 2025 Feb 6.
5
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
6
Optical coherence tomography angiography for detection of microvascular changes in early diabetes: A systematic review and meta-analysis.光学相干断层扫描血管造影术在早期糖尿病微血管变化检测中的应用:系统评价和荟萃分析。
Diabetes Metab Res Rev. 2024 May;40(4):e3812. doi: 10.1002/dmrr.3812.
7
Optical coherence tomography and angiography reveal early retinal alterations in pediatric-onset multiple sclerosis.光学相干断层扫描和血管造影显示儿童期多发性硬化症患者早期视网膜改变。
Eur J Pediatr. 2025 Jun 6;184(7):398. doi: 10.1007/s00431-025-06234-1.
8
Clinical and imaging characteristics associated with foveal neovascularization in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中与黄斑中心凹新生血管相关的临床和影像学特征。
Graefes Arch Clin Exp Ophthalmol. 2025 Mar;263(3):679-687. doi: 10.1007/s00417-024-06660-1. Epub 2024 Nov 15.
9
Beyond pelvic pathology: retinal microvascular rarefaction as a systemic marker in endometriosis.超越盆腔病理学:视网膜微血管稀疏作为子宫内膜异位症的一种全身标志物
BMC Womens Health. 2025 Jul 10;25(1):343. doi: 10.1186/s12905-025-03899-6.
10
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.

引用本文的文献

1
Cerebral Amyloid Deposition With F-Florbetapir PET Mediates Retinal Vascular Density and Cognitive Impairment in Alzheimer's Disease.F-氟比他吡PET检测的脑淀粉样蛋白沉积介导阿尔茨海默病患者的视网膜血管密度及认知障碍
Hum Brain Mapp. 2025 Aug 1;46(11):e70310. doi: 10.1002/hbm.70310.
2
Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta-analysis.轻度认知障碍和阿尔茨海默病中的视网膜血管生物标志物:一项全面综述和荟萃分析。
Alzheimers Dement (Amst). 2025 Jun 16;17(2):e70132. doi: 10.1002/dad2.70132. eCollection 2025 Apr-Jun.

本文引用的文献

1
Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change.用于预测阿尔茨海默病神经病理变化的血浆生物标志物。
Acta Neuropathol. 2023 Jul;146(1):13-29. doi: 10.1007/s00401-023-02594-w. Epub 2023 Jun 3.
2
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease.阿尔茨海默病协会关于阿尔茨海默病血液生物标志物的合理使用建议。
Alzheimers Dement. 2022 Dec;18(12):2669-2686. doi: 10.1002/alz.12756. Epub 2022 Jul 31.
3
Neuropathology of Vascular Brain Health: Insights From Ex Vivo Magnetic Resonance Imaging-Histopathology Studies in Cerebral Small Vessel Disease.
血管性大脑健康的神经病理学:脑小血管病的离体磁共振成像-组织病理学研究的新见解。
Stroke. 2022 Feb;53(2):404-415. doi: 10.1161/STROKEAHA.121.032608. Epub 2022 Jan 10.
4
Optical coherence tomography angiography in Alzheimer's disease: a systematic review and meta-analysis.阿尔茨海默病的光学相干断层扫描血管造影:系统评价和荟萃分析。
Eye (Lond). 2022 Jul;36(7):1419-1426. doi: 10.1038/s41433-021-01648-1. Epub 2021 Jun 30.
5
Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations.阿尔茨海默病的血浆生物标志物可改善认知未受损的老年人群认知能力下降的预测。
Nat Commun. 2021 Jun 11;12(1):3555. doi: 10.1038/s41467-021-23746-0.
6
Prevalence and Heterogeneity of Cerebrovascular Disease Imaging Lesions.脑血管病影像学病变的流行率和异质性。
Mayo Clin Proc. 2020 Jun;95(6):1195-1205. doi: 10.1016/j.mayocp.2020.01.028.
7
Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.社区老年人队列中脑白质高信号的神经病理学相关性。
J Alzheimers Dis. 2020;73(1):333-345. doi: 10.3233/JAD-190687.
8
Retinal Microvascular and Neurodegenerative Changes in Alzheimer's Disease and Mild Cognitive Impairment Compared with Control Participants.与对照参与者相比,阿尔茨海默病和轻度认知障碍中的视网膜微血管和神经退行性变化
Ophthalmol Retina. 2019 Jun;3(6):489-499. doi: 10.1016/j.oret.2019.02.002. Epub 2019 Mar 11.
9
Optical coherence tomography angiography in preclinical Alzheimer's disease.光学相干断层扫描血管造影在临床前阿尔茨海默病中的应用。
Br J Ophthalmol. 2020 Feb;104(2):157-161. doi: 10.1136/bjophthalmol-2019-314127. Epub 2019 May 22.
10
Cerebral microbleeds: Prevalence and relationship to amyloid burden.脑微出血:患病率与淀粉样蛋白负担的关系。
Neurology. 2019 Jan 15;92(3):e253-e262. doi: 10.1212/WNL.0000000000006780. Epub 2018 Dec 19.